The outcome of lupus nephritis in Jamaican patients

American Journal of the Medical Sciences

Volumn 334, Issue 6, 2007, Pages 426-430

  Williams, Winston ^a   Sargeant, Lincoln A ^b   Smikle, Monica ^a   Smith, Roger ^a   Edwards, Heron ^a   Shah, Dipak ^a  

^a UNIVERSITY OF THE WEST INDIES   (Jamaica)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Blacks; Jamaican; Lupus nephritis; Outcome

Indexed keywords

CREATININE; HEMOGLOBIN;

ADULT; ARTICLE; CHRONICITY; CREATININE BLOOD LEVEL; DEATH; FEMALE; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; INTERSTITIAL NEPHRITIS; JAMAICA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PROGNOSIS; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CREATININE; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; HEMATURIA; HEMOGLOBINS; HUMANS; HYPERTENSION; JAMAICA; KAPLAN-MEIER ESTIMATE; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROGNOSIS; PROTEINURIA; TREATMENT OUTCOME;

EID: 37349018036     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3180de4997     Document Type: Article

References (19)

1. Boumpas DT, Austin HA III, Vaughn EM, et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992;340:741-5.
2. Gourley MF, Austin HA III, Scott D, et al. Methylpred-nisolone and cyclophosphamide alone or in combination in severe lupus nephritis: a randomized controlled trial. Ann Intern Med 1996;125:549-57.
3. Austin HA III, Klippel JH, Balow JE, et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-9.
4. Balow JE, Austin HA III. Therapy of membranous nephropathy in systemic lupus erythematosus. Semin Nephrol 2003;23:386-91.
5. Dooley MA, Hogan S, Jennette C, et al. Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans: Glomerular Disease Collaborative Network. Kidney Int 1997;51:1188-95.
6. Williams W, Bhagwandass A, Sargeant LA, et al. Severity of systemic lupus erythematosus and diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients. Lupus 2003;12:640-5.
7. Williams W, Shah D, Sargeant LA. The clinical and epidemiologic features in 140 patients with lupus nephritis in a predominantly black population from one centre in Kingston, Jamaica. Am J Med Sci 2004;327:324-9.
8. Tan EM, Cohen AS, Fries J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
9. Williams W, Shah DJ, Morgan AG, et al. Membranous glomerulonephropathy with crescents in systemic lupus erythematosus. Am J Nephrol 1985;5:158-62.
10. Churg J, Bernstein J, Glassok RJ. Lupus nephritis. In: Churg J, Bernstein J, Glassok RJ, eds. Classification and Atlas of Glomerular Diseases. New York, Igakasis-Shoin, 1995, p 151.
11. Austin HA III, Muenz LR, Joyce KM, et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int 1984;25:689-95.
12. Reveille JD, Bartolucci A, Alarcon GS. Prognosis in systemic lupus erythematosus: negative impact of increasing age at onset, black race and thrombocytopenia as well as causes of death. Arthritis Rheum 1990;33:37-48.
13. Austin HA III, Boumpas DT, Vaughan EM, et al. Predicting renal outcome in severe lupus nephritis, contributions of clinical and histologic data. Kidney Int 1994;45:544-50.
14. Falk RJ. Glomerular diseases. In: Knochel JP, ed. Medical Knowledge Self Assessment Program in Subspecialty of Nephrology and Hypertension. Philadelphia, American College of Physicians, 1994, pp 90-111.
15. Houssiau FA. Management of lupus nephritis: an update. J Am Soc Nephrol 2004;15:2694-704.
16. Tam LS, Li EK, Chan YK, et al. Mesangial lupus nephritis in Chinese is associated with a high rate of transformation to higher grade nephritis. Lupus 2003;12:665-71.
17. Contreras G, Pardo V, Leclerq B, et al. Sequential therapy for proliferative lupus glomerulonephritis. N Engl J Med 2004;350:971-80.
18. Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis: Hong Kong-Guangzhou Nephrology study Group. N Engl J Med 2000;343:1156-1162.
19. Houssiau FA, Vasconcelos C, D'Cruz D, et al. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial: a randomized trial of low dose versus high dose intravenous cyclophosphamide. Arthritis Rheum 2002;46:2121-31.